Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immune Cell Vaccine for Cancer Publisher



Razi S1, 2 ; Rezaei N3, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2018


Abstract

Cancer vaccines have been studied for several years. The focus of these vaccines is treatment of patients with cancer. One of the several types of these vaccines is immune cell vaccine. Dendritic cells (DCs), which are a type of antigen presenting cells, have been widely used for development of immune cell vaccines. These cells can be loaded with different tumor-associated antigens (TAAs), including whole tumor cell lysates, RNA, peptides, and tumor cells. Patients receive these DC-based vaccines, then the DCs present TAAs to immune system and activate antigen-specific immune responses against the tumor. This chapter will briefly explain the DC-based tumor vaccines, their clinical trials, advantages and disadvantages, and then will discuss several methods that can help to optimize these vaccines. © 2019 Nima Rezaei and Mahsa Keshavarz-Fathi Published by Elsevier Ltd All rights reserved.
Related Docs
View other Related Docs
1. Immune Cell Vaccine For Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
2. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms, Vaccines (2022)
3. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
4. Immunopathology and Immunotherapy of Central Nervous System Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
5. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
6. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
7. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
8. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (9)
Jamshid Hadjati (3)
Other Related Docs
9. Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review, Brain Sciences (2023)
10. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
11. Genetic Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
12. Introduction on Cancer Immunology and Immunotherapy, Cancer Immunology: A Translational Medicine Context (2015)
13. Therapeutic Efficacy of Specific Immunotherapy for Glioma: A Systematic Review and Meta-Analysis, Reviews in the Neurosciences (2018)
14. Myeloid-Derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-Based Vaccine Function and Improved Immunity in Tumor Mice, Iranian Journal of Allergy# Asthma and Immunology (2018)
15. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
16. Low Noncytotoxic Concentrations of 5-Fluorouracil Have No Adverse Effects on Maturation and Function of Bone Marrow-Derived Dendritic Cells in Vitro: A Potentially Safe Adjuvant for Dendritic Cell-Based Cancer Therapy, International Archives of Allergy and Immunology (2015)
17. Dendritic Cell Based Immunotherapy Using Tumor Stem Cells Mediates Potent Antitumor Immune Responses, Cancer Letters (2016)
18. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
19. Immune Therapy of Melanoma: Overview of Therapeutic Vaccines, Journal of Cellular Physiology (2019)
20. Introduction on Cancer Immunology and Immunotherapy, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)